Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 780,600 shares, a decrease of 19.8% from the May 31st total of 973,100 shares. Currently, 2.3% of the shares of the company are short […]
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential Novel Approach to Immunotherapy Based on Inhibition of ITK with Soquelitinib (CPI-818) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential Novel Approach to Immunotherapy Based on Inhibition of ITK with Soquelitinib (CPI-818) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) fell 1.7% during trading on Tuesday . The company traded as low as $2.23 and last traded at $2.25. 153,512 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,148,757 shares. The stock had previously closed at $2.29. Wall Street Analysts […]
Corvus Pharmaceuticals Presents New Ciforadenant Preclinical Data at the 2nd JCA-AACR Precision Cancer Medicine International Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.